Treatment failure among kenyan children with severe pneumonia-a cohort study

Pediatric Infectious Disease Journal

Volumn 31, Issue 9, 2012, Pages

  Webb, Clare ^a   Ngama, Mwanajuma ^a   Ngatia, Anthony ^a   Shebbe, Mohammed ^a   Morpeth, Susan ^a   Mwarumba, Salim ^a   Bett, Ann ^a   Nokes, D James ^a,b   Seale, Anna C ^a,b   Kazungu, Sidi ^a   Munywoki, Patrick ^a   Hammitt, Laura L ^a   Scott, J Anthony G ^a,c   Berkley, James A ^a,c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Kenya; pneumonia; treatment failure

Indexed keywords

ANTIBIOTIC AGENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEMOGLOBIN; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CHILD; CHILD HOSPITALIZATION; COHORT ANALYSIS; COUGHING; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY INTERVENTION; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HIV TEST; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; MALNUTRITION; OUTCOME ASSESSMENT; OXYGEN SATURATION; PARASITEMIA; PNEUMONIA; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RURAL AREA; SEPSIS; SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; UPPER RESPIRATORY TRACT INFECTION;

CHILD NUTRITION DISORDERS; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT NUTRITION DISORDERS; KENYA; MALE; ODDS RATIO; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 84865453721     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182638012     Document Type: Article

References (32)

1. Bryce J, Boschi-Pinto C, Shibuya K, et al. WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet. 2005;365:1147-1152.
2. Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86:408-416.
3. Black RE, Cousens S, Johnson HL, et al. Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375: 1969-1987.
4. World Health Organization. Acute Respiratory Infections in Children: Case Management in Small Hospitals in Developing Countries. A Manual for Doctors and Other Senior Health Workers. Geneva, Switzerland: World Health Organization; 1990.
5. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369:1440-1451.
6. Jeena P, Thea DM, MacLeod WB, et al. Amoxicillin Penicillin Pneumonia International Study (APPIS Group). Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia. Bull World Health Organ. 2006;84: 269-275.
7. World Health Organization. Department of Child and Adolescent Health and Development. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Illnesses With Limited Resources. Geneva, Switzerland: World Health Organization; 2005.
8. Cowgill KD, Ndiritu M, Nyiro J, et al. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA. 2006;296:671-678.
9. Berkley JA, Munywoki P, Ngama M, et al. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA. 2010;303:2051-2057.
10. World Health Organization. Management of Children With Pneumonia and HIV in Low-resource Settings. Report of a Consultative Meeting. Harare, Zimbabwe. Geneva, Switzerland: World Health Organization; 2003.
11. Hazir T, Qazi SA, Bin Nisar Y, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan. Arch Dis Child. 2007;92:291-297.
12. Asghar R, Banajeh S, Egas J, et al. Severe Pneumonia Evaluation Antimicrobial Research Study Group. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). BMJ. 2008;336:80-84.
13. Ayieko P, English M. Case management of childhood pneumonia in developing countries. Pediatr Infect Dis J. 2007;26:432-440.
14. Addo-Yobo E, Chisaka N, Hassan M, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet. 2004;364:1141-1148.
15. Hazir T, Fox LM, Nisar YB, et al. New Outpatient Short-Course Home Oral Therapy for Severe Pneumonia Study Group. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet. 2008;371:49-56.
16. Rasmussen ZA, Bari A, Qazi S, et al. Pakistan COMET (Cotrimoxazole Multicentre Efficacy) Study Group. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan. Bull World Health Organ. 2005;83:10-19.
17. Shann F, Barker J, Poore P. Chloramphenicol alone versus chloramphenicol plus penicillin for severe pneumonia in children. Lancet. 1985;2: 684-686.
18. Straus WL, Qazi SA, Kundi Z, et al. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group. Lancet. 1998;352:270-274.
19. Duke T, Poka H, Dale F, et al. Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet. 2002;359:474-480.
20. Addo-Yobo E, Anh DD, El-Sayed HF, et al. for the Multicenter Amoxicillin Severe pneumonia Study (MASS) Group. Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study. Trop Med Int Health. 2011;16:995-1006.
21. Sigaúque B, Roca A, Bassat Q, et al. Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. J Trop Pediatr. 2009;55:379-387.
22. Nantanda R, Hildenwall H, Peterson S, et al. Bacterial aetiology and outcome in children with severe pneumonia in Uganda. Ann Trop Paediatr. 2008;28:253-260.
23. Scott JA, English M. What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal vaccines in developing countries? PLoS Med. 2008;5:e86.
24. Hildenwall H, Nantanda R, Tumwine JK, et al. Care-seeking in the development of severe community acquired pneumonia in Ugandan children. Ann Trop Paediatr. 2009;29:281-289.
25. Källander K, Hildenwall H, Waiswa P, et al. Delayed care seeking for fatal pneumonia in children aged under five years in Uganda: a case-series study. Bull World Health Organ. 2008;86:332-338.
26. Theodoratou E, Al-Jilaihawi S, Woodward F, et al. The effect of case management on childhood pneumonia mortality in developing countries. Int J Epidemiol. 2010;39 (suppl 1):i155-i171.
27. Yeboah-Antwi K, Pilingana P, Macleod WB, et al. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial. PLoS Med. 2010;7:e1000340.
28. Sandora TJ, Desai R, Miko BA, et al. Assessing quality indicators for pediatric community-acquired pneumonia. Am J Med Qual. 2009;24:419-427.
29. Muszynski JA, Knatz NL, Sargel CL, et al. Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial community-acquired pneumonia in children. Pediatr Infect Dis J. 2011;30:295-301.
30. Maitland K, Kiguli S, Opoka RO, et al. FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364:2483-2495.
31. Onyango FE, Steinhoff MC, Wafula EM, et al. Hypoxaemia in young Kenyan children with acute lower respiratory infection. BMJ. 1993;306: 612-615.
32. Thilo EH, Park-Moore B, Berman ER, et al. Oxygen saturation by pulse oximetry in healthy infants at an altitude of 1610 m (5280 ft). What is normal? Am J Dis Child. 1991;145:1137-1140.